It is generally recommended to undergo cervical cancer screening every 3-5 years after receiving the HPV vaccine. The specific screening frequency needs to be comprehensively evaluated based on vaccine type, age, and personal health history. After receiving the bivalent or quadrivalent HPV vaccine, it is usually recommended to undergo cervical cancer screening every 5 years starting from the age of 25. If the 9-valent vaccine is used and there are no high-risk factors, the interval can be appropriately extended. Women over 30 years old still need to maintain regular screening even after completing the full course of vaccination, as the vaccine does not cover all high-risk HPV viruses. The screening method mainly involves cervical cytology examination combined with HPV testing, and in some areas, a single testing method may be used. The first screening time after vaccination can be consulted with a doctor. If there is a history of cervical lesions or immune deficiencies, the screening period should be shortened to 1-3 years. The screening frequency is not fixed and needs to be dynamically adjusted based on each result.

Daily attention should be paid to observing symptoms such as abnormal vaginal bleeding and increased secretions, and seeking medical attention for follow-up examinations in a timely manner. maintaining a regular schedule, balanced diet, and safe sexual behavior can help reduce the risk of infection and avoid behaviors that damage the immune system, such as smoking. No special preparation is required before and after screening, but it is necessary to avoid the menstrual period. Sexual activity and vaginal medication should be avoided 48 hours before the examination.
Comments (0)
Leave a Comment
No comments yet
Be the first to share your thoughts!